NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ:NVAX). Such investors are advised to ...

The government’s deal with Maryland-based Novavax requires the company to obtain regulatory approval for a vaccine using ingredients made at the Biologics Manufacturing Centre (BMC) in Montreal before ...

The multibillionaire South African-born immigrant also admitted in an email that he “had no legal right to stay in the country” when he ditched his studies and founded a company which he later ...

About a week later, the agency authorized an updated version of Novavax’s protein subunit vaccine for people 12 years and older. The mRNA vaccines specifically target KP.2, a subvariant of JN.

Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined Covid-flu vaccine and standalone flu inoculation due to safety concerns.

Novavax's planned phase 3 clinical trials just hit a roadblock. The stock didn't look that attractive before this development. This setback adds more uncertainty to Novavax's prospects. However ...

The company was founded by PureTech Health, the same Boston-based startup incubator that established Karuna Therapeutics 15 years ago. Karuna led the charge developing a new class of antipsychotic ...

In early pandemic days, Novavax (NASDAQ: NVAX) shares soared as investors bet on the company's ability to bring a coronavirus vaccine to market. But as the biotech fell behind in the race and ...

Novavax has been gearing up to launch a phase 3 trial of what may result in an important product: A combined flu and coronavirus vaccine. But the company now faces a roadblock, saying regulators ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Montana Sen. Jon Tester's campaign reportedly amplified attempts to disparage Republican opponent Tim Sheehy's business ahead of the election, The Wall Street Journal reported. Sheehy, the Navy ...